View in EDS HTML Full Text PDF Full Text

Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.

Saved in:
Bibliographic Details
Title: Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.
Authors: Pawlyn C; The Institute of Cancer Research, London, UK. charlotte.pawlyn@icr.ac.uk.; The Royal Marsden Hospital NHS Foundation Trust, London, UK. charlotte.pawlyn@icr.ac.uk., Schjesvold FH; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Cairns DA; Leeds Cancer Research UK Clinical Trials Unit of Leeds, Leeds, UK., Wei LJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Davies F; Perlmutter Cancer Center, NYU Langone, New York, NY, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA., Abdulhaq H; University of California, San Francisco, Fresno Campus, CA, USA., Mateos MV; University Hospital of Salamanca; IBSAL; Institute of Cancer Molecular and Cellular Biology; and CIBERONC, Salamanca, Spain., Laubach J; Dana-Farber Cancer Institute, Boston, MA, USA., Weisel K; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany., Ludwig H; Medical Department Center for Oncology, Hematology and Palliative Medicine, Wilhelminen Cancer Research Institute, Vienna, Austria., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jackson G; Northern Centre for Cancer Care, Newcastle Upon Tyne Hospitals Trust, Newcastle Upon Tyne, UK., Morgan G; Perlmutter Cancer Center, NYU Langone, New York, NY, USA., Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA.
Source: Blood cancer journal [Blood Cancer J] 2024 Aug 12; Vol. 14 (1), pp. 134. Date of Electronic Publication: 2024 Aug 12.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39134544
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pawlyn+C%22">Pawlyn C</searchLink>; The Institute of Cancer Research, London, UK. charlotte.pawlyn@icr.ac.uk.; The Royal Marsden Hospital NHS Foundation Trust, London, UK. charlotte.pawlyn@icr.ac.uk.<br /><searchLink fieldCode="AU" term="%22Schjesvold+FH%22">Schjesvold FH</searchLink>; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Cairns+DA%22">Cairns DA</searchLink>; Leeds Cancer Research UK Clinical Trials Unit of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Wei+LJ%22">Wei LJ</searchLink>; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Davies+F%22">Davies F</searchLink>; Perlmutter Cancer Center, NYU Langone, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nadeem+O%22">Nadeem O</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Abdulhaq+H%22">Abdulhaq H</searchLink>; University of California, San Francisco, Fresno Campus, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; University Hospital of Salamanca; IBSAL; Institute of Cancer Molecular and Cellular Biology; and CIBERONC, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Laubach+J%22">Laubach J</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ludwig+H%22">Ludwig H</searchLink>; Medical Department Center for Oncology, Hematology and Palliative Medicine, Wilhelminen Cancer Research Institute, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Rajkumar+SV%22">Rajkumar SV</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Sonneveld+P%22">Sonneveld P</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jackson+G%22">Jackson G</searchLink>; Northern Centre for Cancer Care, Newcastle Upon Tyne Hospitals Trust, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Morgan+G%22">Morgan G</searchLink>; Perlmutter Cancer Center, NYU Langone, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Aug 12; Vol. 14 (1), pp. 134. <i>Date of Electronic Publication: </i>2024 Aug 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39134544
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-01109-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 134
    Titles:
      – TitleFull: Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pawlyn C
      – PersonEntity:
          Name:
            NameFull: Schjesvold FH
      – PersonEntity:
          Name:
            NameFull: Cairns DA
      – PersonEntity:
          Name:
            NameFull: Wei LJ
      – PersonEntity:
          Name:
            NameFull: Davies F
      – PersonEntity:
          Name:
            NameFull: Nadeem O
      – PersonEntity:
          Name:
            NameFull: Abdulhaq H
      – PersonEntity:
          Name:
            NameFull: Mateos MV
      – PersonEntity:
          Name:
            NameFull: Laubach J
      – PersonEntity:
          Name:
            NameFull: Weisel K
      – PersonEntity:
          Name:
            NameFull: Ludwig H
      – PersonEntity:
          Name:
            NameFull: Rajkumar SV
      – PersonEntity:
          Name:
            NameFull: Sonneveld P
      – PersonEntity:
          Name:
            NameFull: Jackson G
      – PersonEntity:
          Name:
            NameFull: Morgan G
      – PersonEntity:
          Name:
            NameFull: Richardson PG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 08
              Text: 2024 Aug 12
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1